03 Jun
Member News

Jaguar Freight | The Weekly Roar – Top Shipping News

In this week’s Roar: diesel at a two-year low, new FMC rules in force, port congestion in Singapore, good news for air cargo demand, and the real costs of the Red Sea conflict. Diesel prices continue to fall, with the U.S. price reaching its lowest point in the past two years. The average price per gallon is now $3.758, which is 30.3 cents lower than the price was on April 8, 2024. Prices are down in nine out of the...

Read more

31 May
Member News

Vulcan View: The latest EU developments 27 May – 31 May

What a Labour Government means for the UK Economy With the UK General Election cycle having completed its first week, the pressure has been on the Labour Party, who hold a significant polling lead over the Tories, to provide details on what exactly a Labour government means for the United Kingdom? In particular, what can voters expect from Sir Kier Starmer’s party on the economy. In her first speech on the campaign trail, Shadow Chancellor Rachel Reeves MP provided some insights into...

Read more

31 May
Chapter News

IMF | Why I Remain Optimistic About Global Economic Cooperation

Acceptance Speech by Kristalina Georgieva, IMF Managing Director, Venice, Italy President Mattarella, Governor Visco, Mayor Brugnaro; Professors Lippiello and La Malfa; Commissioner Gentiloni; all of you who have come here today: I am deeply grateful for your presence and for the honor of being the first recipient of the Ugo la Malfa Prize for International Cooperation from the Università Ca Foscari Venezia, the Enciclopedia Treccani, and the Fondazione Ugo La Malfa. I will cherish it and will work hard to serve our family of...

Read more

30 May
Member News, Uncategorized

Wilson Sonsini | The Entrepreneurs Report – Private Company Financing Trends: Q1 2024

Key Features and Developments in This Report Celebrating Asian American and Pacific Islander Heritage Month In a compelling interview, Wilson Sonsini partner Salil Gandhi talks with Notable’s Robin Li. They delve into the influence of Li's identity and personal experiences on her career trajectory and explore the changing landscape of Asian American & Pacific Islander representation in the tech and venture capital sectors.   Valuations Show Mixed Signs of Recovery Early 2024 saw mixed signals in early-stage valuations, following notable highs in the previous...

Read more

30 May
Member News

Sika | Sika received SBTi validation for its net-zero targets

Sika’s near and long-term emissions reduction targets, aiming for net-zero emissions by 2050, have been validated by the Science Based Targets initiative (SBTi)1. This important achievement underscores Sika’s commitment to sustainability and its proactive role in decarbonizing the construction and automotive industries.   By 2032, Sika is committed to reducing its greenhouse gas (GHG) emissions by 50.4% compared to the 2022 baseline, for scope 1 and scope 2 emissions, whilst advancing its growth strategy. These include direct emissions from owned or controlled...

Read more

29 May
Chapter News

European Council | Industrial policy: Council gives final approval to the net-zero industry act

The Council has today adopted a regulation on establishing a framework of measures for strengthening Europe's net-zero technology manufacturing ecosystem, better known as the 'net-zero industry act'. This is the last step in the decision-making process. The regulation aims to boost the industrial deployment of net-zero technologies that are needed to achieve the EU's climate goals, using the strength of the single market to reinforce Europe’s position as a leader in industrial green technologies. "The net-zero industry act is one of the...

Read more

29 May
Chapter News

OECD | Developed countries materially surpassed their USD 100 billion climate finance commitment in 2022

Developed countries provided and mobilised USD 115.9 billion in climate finance for developing countries in 2022, exceeding the annual 100 billion goal for the first time and reaching a level that had not been expected before 2025. According to new figures from the OECD, in 2022 climate finance was up by 30% from 2021, or by USD 26.3 billion. This is the biggest year-on-year increase to date and means that the 100 billion mark was reached a year earlier than...

Read more

29 May
Chapter News

IMF | Europe Can Reap Sizable Energy Security Rewards by Scaling Up Climate Action

Meeting the continent’s emission reduction targets could enhance energy security metrics by 8 percent by 2030—and that would be just the start Blog post by Geoffroy Dolphin, Romain Duval, Galen Sher, Hugo Rojas-Romagosa | Russia’s invasion of Ukraine triggered Europe’s worst energy crisis since the 1970s and put energy security back at the top of the policy agenda. Policymakers reacted swiftly by securing alternative natural gas supplies, improving energy efficiency, and expanding renewables. Reducing greenhouse gas emissions would, they said, not only mitigate climate...

Read more

29 May
Member News

CLA Outlook for Q2 2024: Resilience, Growth in a Transformative Market

Key insights • Trends indicate a robust economy supported by strong consumer spending and transformative wealth transfers. CLA is predicting the rest of 2024 is characterized by a sense of resilience and optimism. • Market sentiment is leaning toward a growth mindset, with the economy showing strength and businesses focusing on expanding and managing costs effectively. • Within investing, a diversified portfolio is strategically designed to mitigate market volatility. It serves to both preserve and augment capital. Curious about the many benefits of...

Read more

28 May
Member News

Troutman Pepper | Accelerated Approval Process Is Not Without Risk: Placing Recent FDA Action in Context

On February 23, the Food and Drug Administration (FDA) withdrew approval of Pepaxto (melphalan flufenamide), a drug that it had previously granted accelerated approval for treatment of multiple myeloma. The decision came after a post-marketing, confirmatory study of Pepaxto failed to confirm the drug’s clinical benefit, and FDA determined that available evidence demonstrated that Pepaxto was not shown to be safe or effective under its conditions of use. Although accelerated approval remains an important pathway for sponsors to make...

Read more

«‹133134135136137›»